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a b s t r a c t
BMP signaling plays an essential role in second heart ﬁeld-derived heart and arterial trunk development,
including myocardial differentiation, right ventricular growth, and interventricular, outﬂow tract and
aortico-pulmonary septation. It is mediated by a number of different BMP ligands, and receptors, many
of which are present simultaneously. The mechanisms by which they regulate morphogenetic events
and degree of redundancy amongst them have still to be elucidated. We therefore assessed the role of
BMP Type I receptor AcvR1 in anterior second heart ﬁeld-derived cell development, and compared it
with that of BmpR1a.
By removing Acvr1 using the driver Mef2c[AHF]-Cre, we show that AcvR1 plays an essential role in
arterial pole morphogenesis, identifying defects in outﬂow tract wall and cushion morphology that
preceded a spectrum of septation defects from double outlet right ventricle to common arterial trunk in
mutants. Its absence caused dysregulation in gene expression important for myocardial differentiation
(Isl1, Fgf8) and regional identity (Tbx2, Tbx3, Tbx20, Tgfb2). Although these defects resemble to some
degree those in the equivalent Bmpr1a mutant, a novel gene knock-in model in which Bmpr1a was
expressed in the Acvr1 locus only partially restored septation in Acvr1 mutants. These data show that
both BmpR1a and AcvR1 are needed for normal heart development, in which they play some non-
redundant roles, and reﬁne our understanding of the genetic and morphogenetic processes underlying
Bmp-mediated heart development important in human congenital heart disease.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Heart morphogenesis is a complex process involving many
secreted growth factors and their receptors (reviewed by Bruneau
(2013)). Bone morphogenetic protein (BMP)-mediated signaling
has been strongly implicated in the process by which separate
ventricular outlets, valves and arterial trunks are formed from a
single tube by septation requiring precise shape and positioning of
contributory structures (reviewed by Dyer and Kirby (2009)).
Failure in this process results in formation of outﬂow tract (OFT)
septation defects, one of the common cardiac birth defects in
humans.
The arterial pole of the developing heart is largely composed
of mesodermally-derived second heart ﬁeld (SHF), which forms
myocardium of the interventricular septum and right ventricle
(RV), and myocardium and future smooth muscle (arterial trunk)
of the OFT wall. It also contributes to the adjacent endocardium,
and cushion mesenchyme, especially proximally, by endocardial-
to-mesenchymal transformation (EMT). The mesenchyme of OFT
cushions is largely composed of cardiac neural crest-derived cells
(CNCC), which also contribute to arterial trunk smooth muscle
(Dyer and Kirby, 2009; Snarr et al., 2008; Verzi et al., 2005).
BMPs have been shown to exert complex, dose-dependent and
even opposing effects on myocardial differentiation, functioning as
both promoters and inhibitors of cardiac growth (de Pater et al.,
2012). It has been suggested that a delicate balance between FGF
and BMP signaling controls proliferation and differentiation of SHF
progenitors (Hutson et al., 2010) and that BMPs can block FGF
signaling (Tirosh-Finkel et al., 2010). In mouse embryos, inactiva-
tion of genes encoding BMPs 2,4 and 7 or BmpR1a (Bone morpho-
genetic protein receptor, type Ia) speciﬁcally in the second heart
ﬁeld has been shown to result in formation of common arterial
trunk and OFT cushion defects (Bai et al., 2013; Briggs et al.,
2013; Wang et al., 2010; Yang et al., 2006). BMPs have also been
shown to regulate myocardial differentiation through a microRNA-
mediated mechanism, and Bmpr1a needed for expression of
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T-box transcription factors Tbx2 and Tbx3. These are important for
myocardial differentiation and arterial pole morphogenesis (Mesbah
et al., 2012; Singh et al., 2012).
BMPs signal via tetrameric transmembrane receptor complexes
composed of two Type II (BmpRII, AcvRIIa or AcvRIIb) and two
Type I (BmpRIa [Alk3], BmpRIb [Alk6] or AcvRI [Alk2; Activin A
receptor, type Is]) receptors (Massague and Chen, 2000). Ligand
binding results in activation of Type I receptor kinase activity,
which subsequently phosphorylates receptor-regulated R-Smads
1,5 or 8 (Derynck and Zhang, 2003). Phosphorylated R-Smads and
Smad4 form a complex which accumulates in the nucleus where it
functions as a transcriptional co-regulator. Evidence suggests there
is a limited degree of redundancy between BMP receptors under-
lying regulation of developmental events (Kishigami and Mishina,
2005). The situation is complex; heteromeric as well as homo-
meric ligand dimers can bind with different binding afﬁnities
to oligomeric receptor complexes composed of different type II
and type I and co-receptors (Ehrlich et al., 2012), at least in model
systems.
Although an essential role for BmpRIa has been demonstrated, it
is not the only type I receptor expressed in the heart. AcvRI has been
shown to play critical roles in endocardial cushion and OFT valve
development in mice (Kaartinen et al., 2004; Thomas et al., 2012;
Wang et al., 2005) and mutations in ACVR1 have been implicated
in congenital cardiac defects in humans (Smith et al., 2009). We
therefore chose to investigate the role of AcvRI speciﬁcally in the
second heart ﬁeld and its derivatives.
Materials and methods
Mice
Mice carrying the conditional Acvr1-ﬂox allele (Acvr1F), Bmpr1a-ﬂox
allele (Bmpr1aF), ‘constitutively active’ Acvr1 conditional allele (ACVR1
carrying Q207D mutation, ‘caAcvr1’) and Mef2c[AHF]-Cre transgenic
mice (kindly provided by BL Black) were used and genotyped as
previously described (Ahn et al., 2001; Fukuda et al., 2006; Kaartinen
and Nagy, 2001; Verzi et al., 2005). Timedmatings between Acvr1KO/WT
Mef2c[AHF]-Creþ males and Acvr1F/F female mice were used to obtain
Alk2F/KOMef2c[AHF]-Creþ tissue-speciﬁc mutant embryos (‘Acvr1-cKO’).
Some females were also R26RYFP/YFP or R26RlacZ/lacZ to enable Mef2c
[AHF]-Cre lineage tracing, and FACS-based isolation of recombined
second heart ﬁeld cells (see below). Controls were either Cre0, or
Acvr1F/WT, Mef2c[AHF]-Creþ littermates (‘Acvr1-cHet’). To generate
other experimental genotypes, females were generated carrying
various combinations of ﬂoxed and wild type alleles of both Acvr1
and Bmpr1a, or with Acvr1Bmpr1a-KI, or Acvr1ACVR1-KI (see below, and
main text), and Bmpr1F/WT Mef2c[AHF]-Creþ and Acvr1F/WT,Bmpr1F/WT,
Mef2c[AHF]-Creþ males.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The experiments
described in this study were speciﬁcally approved by the Uni-
versity Committee on Use and Care of Animals of the University of
Michigan-Ann Arbor (Protocol Number: #09944).
Generation of Acvr1nlsLacZ bac transgenic mice
A nlsLacZ-pA cassette was inserted in frame into the ﬁrst coding
exon of Acvr1 (exon 3) in the bac RP23-366D15 (Children’s Hospital
Oakland Research Institute) by using standard recombineering
techniques (Warming et al., 2005) (see Fig. 5). Bac transgenic mice
were generated in the University of Michigan Transgenic Animal
Model Core. Three of ﬁve founders displayed similar staining
patterns consistent with authentic Acvr1 expression (data not show).
The line #934 was used for further studies.
Generation of Acvr1Bmpr1a-Flag (Bmpr1a-KI) and Acvr1ACVR1-His6Myc
(ACVR1-KI) knockin mice
The coding region of the Bmpr1a cDNA (from ATCC) was subcloned
into pcDNA3.1 vector (Invitrogen), and sequences encoding the Flag-
tag inserted in frame into the 30end of the cDNA by site-directed
mutagenesis (QuikChange II XL; Agilent). A similar strategy was used
to modify human ACVR1A cDNA (kindly provided by R. Derynck) by
inserting sequences encoding the His6/Myc-tag into its 30end. Target-
ing vectors were generated as follows: a long 50 homology arm
covering a 5-kb segment of the mouse genomic DNA upstream of
the Acvr1 translational start in exon 3 and a short 30 homology arm
covering a 2.6-kb segment of DNA downstream of the exon 3/intron
3 boundary were PCR-ampliﬁed using the mouse bac DNA as a
template, and subcloned into a cloning vector containing the Flag-
tagged Bmpr1a-bGHpolyA (or Myc-His6-tagged ACVR1-bGHpolyA)
and the loxP-PGK-Neo-polyA-loxP cassettes (DTA was used a negative
selection marker) (see Fig. 7). Electroporation, screening, validation,
removal of the selection marker, ES cell expansion, blastocyst injec-
tions and production of chimeric and heterozygote mice were
performed according to standard procedures by genOway (France).
LiCl treatment
Pregnant female mice were injected intraperitoneally with LiCl
(200 mg/kg in saline) once a day at E7-E10 (NaCl [200 mg/kg] was
used as a control) as described (Tian et al., 2010).
Histology, immunohistochemistry and in situ hybridization
Embryos for assessment were collected in sterile DBPS and ﬁxed
overnight in commercial 10% formalin or fresh 4% paraformalde-
hyde in PBS at 4 1C overnight. Those for wax embedding were then
washed, dehydrated, and oriented and embedded in fresh Blue
Ribbon Tissue Embedding/Inﬁltration Medium (Leica Surgipath)
after three changes. 7 μm sections were cut and mounted on
Superfrost plus slides (Fisher) and stored at room temperature or
4 1C. Haematoxylin and eosin staining was performed using a
standard protocol, taking care to ensure complete, but not over-,
staining to allow maximum discrimination of cell types. Immuno-
histochemistry (see Supplemental Table 1 for details) performed
on rehydrated wax sections: Antigen retrieval (15 min at 95–100 1C)
in citrate buffer pH6 was used in some cases, tissues blocked with
2–3% BSA, 0.1% Triton-X100 in PBS or TBS prior to incubation with
primary antibodies overnight at 4 1C. Binding was visualized with
Alexaﬂuor-594 or -488-conjugated secondary antibodies (Life Tech-
nologies) on slides mounted with Vectamount/DAPI (Vector Labs).
Some ﬁxed embryos were processed for cryo-embedding:
washed in PBS, allowed to sink in sterile 10% sucrose in PBS, then
7% gelatin (Sigma G6650, 75 bloom), 15% sucrose in PBS, oriented
and embedded in fresh 7% gelatin, 15% sucrose in PBS on ice then
dry ice, and stored at 20 or 80 1C. 10 μm cryo sections were cut
and stored at 20 or 80 1C.
Immunohistochemistry performed on cryo sections
Antigen retrieval was not used unless stronger/more complete
MF20 or α-SMαA signal was needed. α-GFP detected YFP lineage-
tracing but any heat-based antigen retrieval prevented its detection.
For quantiﬁcation of proportion of pSmad1/5/8-positive cells in
OFT column cells, immunoﬂuorescence was performed using α-
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Fig. 1. Abnormal morphology in Acvr1-cKO hearts and trunks. A,Da,Db, P0 hearts; B,C,Ea–Fb, E16 4-chamber H&E: Post-septation stage controls (A,B) have aortic and
pulmonary trunks at right angles to one another, proximal AoT behind sub-pulmonary sleeve (asterisk in A). In ‘mildest’ Acvr1 cKO (Da,Ea,Fa), DORV, trunks parallel to one
another, valves on same level as one another, proximal AoT visible (Da) as subpulmonary sleeve inadequate, insufﬁcient displacement of AoT to the left posterior/PT to the
right anterior. In ‘severe’ Acvr1 cKO (Db,Eb,Fb) single trunk close to valve, though often distally septated to form separate full size (not shown) or rudimentary second trunk
(PT in Eb connected to pulmonary arteries). DORV (Fa), CAT (Fb) accompanied by subvalvular VSD (black arrow). G,H,E9; I,L, E10; hearts in situ from right: Three
representative E9 mutant hearts (H) distinguishable from three controls (G) by variably narrower RV apex (arrow) vs OFT (RVþOFT of these samples used for qRT-PCR,
Figs. 3 and 4). I,J, E9 4-chamber cryosections showing less nuclear phosho-Smad1/5/8 immunostaining (pink) in OFT wall (pink arrows) in Mef2c[AHF]-Cre-recombined cells
(YFP, cyan) in Acvr1-cKO (J) than in Acvr1-cHet control (I). Endocardium also positive (arrowheads). Unrecombined endoderm same in both (phe). E10 control RV broader
(blue arrows) than OFT (K) unlike mutant (N). L,O, Mef2c[AHF]-Cre lineage βgal stain (blue), apical view: control (L) RV is broader laterally (green arrows), proximal OFT
curves to reach midline (green line) unlike mutant (O). N,P, E11, 4-chamber,H&E: mutant (P) RV apex grows but remains narrower laterally than in control (N), though wall
thickness and trabeculation very similar and muscular septum (asterisk) present (contacts AV cushion in different section from N). Scale bar, 200 μm. ‘Rotation’ of OFT less
in mutant hearts. Q–Tb, E12 transverse to OFT, H&E: In control (Q), AP septation complete, distal trunks separate, lying in correct relation to one another; proximal to valve
cushions, parietal and septal cushions (n) lie parallel to A–P axis (R) so RVO anterior-most. In mild mutant, some partial distal trunk septation (Sa) present only, but main OFT
cushions (n) near correct orientation (Ta); in severe mutant, no distal trunk septation, aortic (A) and pulmonary (P) lumens unseparated (Sb). More proximally (Tb), cushion
faces 601 short of normal orientation. Note irregular trunk wall (arrow, Sa,Sb). U–Z, Sema3C expression, E11, WMT ISH; E12, section ISH: In control E11 (U from left, U0 from
anterior) strongest (small arrows) on distal anterior/left face; in mutant (V from left, V0 from anterior) strongest distal left to posterior, less cleanly deﬁned. Expression
extends more proximally in mutant (large arrow). Control E12, valve level (W), strongest myocardial (My) expression on anterior face (RVO) (tissue split anteriorly, d) but in
mutant (Y in which distal septation failed), very weak on anterior face (small arrow), strong posteriorly (arrowhead); positive NC cells abnormally located (large arrow).
Proximally, expression weak in control (X), more extensive in mutant (Z: note abnormal cushionn morphology). d, artifactual damage. Scale bar, 200 μm.
P.S. Thomas et al. / Developmental Biology 390 (2014) 191–207 193
pSmad1/5/8 and either α-Isl1 or MF20 on 10 μm cryostat sections
of E11 control and mutant samples, cut transverse to the OFT.
Using single channel gray scale images and combined color
images, column cells (positive for Isl1 but negative to MF20) were
quantiﬁed in each section, and the proportion showing positive α-
pSmad1/5/8 staining as assessed by comparison with positive non-
recombined cells determined.
For cell proliferation analysis, immunoﬂuorescence was used
on 10 μm cryostat sections cut 4-chamber, parallel to OFT, with
α-phosphohistone3 (PH3) and either MF20, α-GFP or α-Isl1. Every
Fig. 2. Abnormalities in OFT cushions in Acvr1-cKO. A–J, E11, E12 H&E; B–E,G–J transverse to OFT: Parallel to the distal OFT, endocardial contour (arrow) smooth in control
(A) but irregular (arrows) and cushion continuity poor (arrowhead) in mutant (F). Distally, two cushions (par, sep) present in control (B) leave endocardium fairly close to OFT
wall (asterisk), but in mutant (G) one large dysmorphic cushion, with circumferentially oriented cells on left side (arrows), create a greater distance to between wall and
endocardium (asterisk) and functional lumen remains only in right anterior position. Mid-OFT, four cushions (par, sep, I, I) in control (C), abnormal cushion size and location
(asterisks) in mutant (H). Proximal cushions faces are parallel to ﬂow (line) in control (D), but an abnormal pyramidal cushion contour (arrowheads) in mutants (I). By E12,
parietal cushion continuity with AV cushion present (asterisk), wide cushion-free RV outlet (line) anteriorly in control (E) but undersized proximal cushions, no continuity
with AV cushion, no cushion-free outlet space (arrow) in mutant (J). K–S, E11-12, Plxna2 ISH: From both right (K,P) and left (K0 ,P0) Plxna2-positive cells present in both control
(K,K0) and mutant (P,P0) OFT, though staining mid-OFT in mutant (arrows) weaker. Mid-OFT, strong expression in central cells of each main OFT cushion in control (L), faint
misplaced expression in mutant (R). By E12, strong expression in condensed central mesenchyme (arrow) at level of valve septation in control (M), faint in aortic trunk
(arrowhead); faint in mutant cushion (S, arrows) but strong expression in irregular thickness arterial wall (arrowhead). N,T, E10, βgal stain, sagittal sections: in Acvr1-cHet
Mef2c[AHF]-Cre control, numerous recombined mesenchymal cells (blue arrows) underlie recombined endocardium (N) in proximal cushion, but very few in Acvr1-cKO (T).
Unrecombined mesenchyme (white arrows) and endocardium also present. O,U, E11, transverse distal OFT sections, immunostaining: Upper panels show MF20, α-pSmad1/
5/8 immunostaining on sections in which the region including a particular column of SHF-derived cells is indicated by a box (see also Online Fig. 4). Lower panels: darkﬁeld
and color-inverted images show an enlargement of the equivalent areas in sister sections to those in the upper panels, demonstrating that the population of Isl1-positive,
MF20-negative cells there (outlined in color-inverted images) contained more pSmad1/5/8-positive cells in the control than in the mutant sample (quantiﬁcation shown in
bar chart; n¼4, 7SEM, npo0.01). Examples of Isl1-positive, pSmad1/5/8-negative cells (green arrows); Isl1-negative, pSmad1/5/8-positive cells (red arrows); and Isl1-
positive/pSmad1/5/8-positive cells (yellow arrows on darkﬁeld, blue arrows on color-inverted image) identiﬁed. Note many pSmad1/5/8-positive mesenchymal cells in both
control and mutant sections (red cells in color-inverted images). AV, atrioventricular cushion; dOFT, distal OFT; I, intercalated cushion; pOFT, proximal OFT; par, parietal
cushion; sep, septal cushion. Embryonic axes in F,G,M: A, anterior; D, dorsal; L, left; P, posterior; R, right; V, ventral. Scale bar, 200 μm.
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α-PH3-positive wall cell was counted that was also within MF20/
α-GFP-positive region within the morphologically deﬁnable OFT.
MF20-negative second heart ﬁeld cells were not included. Proximal
and distal OFT were distinguished by direction of heart tube. Three
separate control and mutant samples (19–22 pair somite stage) paired
by size were counted and were assessed. Apoptotic cells were
detected using Dead End Fluorometric TUNEL system (Promega)
following manufacturer's instruction.
RNA in situ hybridization
Embryos for ISH were ﬁxed in freshly thawed 4% paraformal-
dehyde in PBS over night at 4 1C. Those for section ISH were
washed and wax-embedded, sectioned at 10 μm and mounted as
described above. DIG-labeled RNA probes (see Supplemental
Table 2 for details) were made using a DIG-labeled NTP mix
(Roche Applied Sciences) according to manufacturer's instructions,
stored at 80, or 20 1C diluted in hybridization buffer. Section
ISH was performed as described (Moorman et al., 2001) with
probes diluted to 1 ng μl1 or less. After staining, sections were
washed, ﬁxed and mounted in Immumount (Thermo Scientiﬁc).
Embryos for wholemount ISH were ﬁxed as above, washed in PBST,
dehydrated and stored in 95% methanol, 5% PBST at 20 1C. After
rehydration they were trimmed to enable access of reagents, visuali-
zation of OFT or other tissues in cross section without sectioning in
some cases, and easy discrimination of controls and mutants (which
were then processed together for all steps), proteinase K-treated, post-
ﬁxed and pre-hybridized rotating for at least 1 h in standard non-SDS-
based hybridization buffer, pH5, at 70 1C. Probe (for ﬁnal concentration
of 0.1–1 ng μl1) was added, or buffer replaced with pre-heated
Fig. 3. Gene expression differences between Acvr1-cKO and controls (I). A, qRT-PCR, E9 and E10, SHF cells (YFPþveMef2c[AHF]-Cre-recombined population, outlined in A0
at E9, from right) FACS-sorted after removing the OFT/heart tube. control, blue bars; Acvr1-cKO, red bars. Average Bmp synexpression gene expression (black underline)
reduced in mutants at both time points. Fgf synexpression target gene expression (gray underline) slightly elevated at E10. Tbx1 expression higher at E9, and Isl1 less at E10 in
mutants. Results are average of nZ3 each control, Acvr1 cKO samples, 7SEM, npr0.05. B, qRT-PCR on E9 RVþOFT (manually dissected region, outlined in B0 , in YFPþve
Mef2c[AHF]-Cre-recombined population). Average BMP target gene expression (black underline) reduced in mutants, Fgf8 expression much higher, but not Fgf10 or FGF
targets. Isl1 and Tbx1 also elevated. C–G, E9, E10 WMT ISH for gene expression reported in B, control on left, mutant on right. C 4-chamber, C0 from right, Smad6 strong in
distal (arrow)-mid OFT and adjacent SHF in control, greatly reduced in mutant (also inner curvature/RAV). Endocardium (arrowhead), LAV and liverbud (asterisk) positive in
both. D, Fgf8 strong distal (arrow) to proximal OFT (arrowhead) in mutant but weak in control; E, Fgf8 stronger, extends more proximally (arrowhead) in mutant. Endoderm
expression strong in all (PA). F, Fgf10 expression similar in both control and mutant, stronger in proximal/mid OFT (purple arrowhead) than distal (white). G, Isl1 strong
distally (arrows) but also extends to mid-OFT (arrowhead) in mutant. dOFT, mOFT, distal, mid, outﬂow tract npr0.05. Scale bar, 200 μm.
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previously used probe in hyb buffer, and left rolling overnight. Used
probe was recovered and stored at 20 1C, but discarded when
staining level reduced. Embryos were then washed (rolling) for
20 min three times in pre-heated hybridization buffer at 70 1C, once
in hybridization buffer/TBST, then in at least 6 changes of TBST at room
temperature over 1 h, blocked in 0.05% Roche block (one hour)
and rocked O/N at 4 oC with α-DIG Fab fragments (Roche Applied
Sciences,1:2000–5000); washed with 10 changes of TBST the next day
(RT), rolling, over several hours, and O/N at 4 1C, stationary if E9 or 10;
rolled for 10 min (RT) twice in NTMT pH9.5, and stained with BM
Purple AP substrate or 1 NBT/BCIP (Roche Applied Sciences) at RT in
the dark, overnight if necessary. Stained embryos were washed several
times in PBS, ﬁxed in formalin and stored at 4 1C. Some were
dehydrated through graded ethanols and Histoclear (National Diag-
nostics), wax-embedded, sectioned at 7–10 μm and mounted in
Immumount (Thermo Scientiﬁc).
β-Galactosidase staining
Embryos for wholemount staining (for Mef2c[AHF]-Cre, R26RlacZ
lineage tracing, or Acvr1nlsLacZ detection (see below)) were ﬁxed for
15 min in 0.5% glutaraldehyde in DPBS, washed at least three times
Fig. 4. Gene expression differences between Acvr1-cKO and controls (II). A, qRT-PCR on E9 RVþOFT for muscle-related gene expression differentiation (control, blue;
mutant, red): Though average expression of sarcomeric protein genesMyh7,Myh6 not affected,Myl7 lower,Myh11 andMyh3 higher (expression levels too low for WMT ISH).
Tdgf1 (Cripto) variably higher, Wnt2 lower in mutants. Results are average of nZ3 each control, Acvr1 cKO samples, 7SEM, npr0.05. B–D E9, E10 WMT ISH for gene
expression reported in A, control on the left, mutant on the right: B, Tdgf1 expressed in OFT distally (arrows) to mid/proximally (arrowhead) more strongly in mutant than
control, still detectable E10 (arrowheads) only in mutants. L, Wnt2 detectable throughout OFT (arrowheads) but not in mutant. E, qRT-PCR on E9 RVþOFT, SHF for average
Bmp/Tbx regional gene expression, control blue, mutant red: Tbx2, Tbx3, Tbx20, Tgfb2, Ccnd2 all reduced in mutant RVþOFT; Tbx2, 3 not affected in mutant SHF; Has2, Bmp4
no difference; Bmp2 higher in mutant RVþOFT. Results are average of nZ3 each control, Acvr1 cKO samples, 7SEM. npr0.05. F–H, WMT ISH and proliferation related to
gene expression reported in E, control on the left, mutant on the right: F, Nppa expressed more broadly mid-OFT in mutant (arrows); G, Tgfb2much lower mid-proximal OFT
(arrowheads) in mutant. H, average proliferation higher in mutant than control MF20 (cyan)-positive OFT wall (α-PH3-labeled nucleus: pink arrow): bar chart (n¼3 control,
mutant) on left, representative sections of control (middle) and mutant (right). aos, aortic sac; dOFT, pOFT distal, proximal outﬂow tract; PA pharyngeal arch; PH3, phospho-
histone 3. npr0.05. Scale bar, 200 μm.
P.S. Thomas et al. / Developmental Biology 390 (2014) 191–207196
in detergent rinse, then stained using standard procedures (Hogan
et al., 1994). After sufﬁcient staining had occurred, embryos were
washed in detergent rinse and PBS and ﬁxed in formalin. Some
were processed to wax using Histoclear (National Diagnostics),
sectioned at 7 or 10 μm, and mounted in Immumount (Thermo
Scientiﬁc).
Microscopy and photography
Results were viewed and recorded on an Olympus BX51
(sections, bright ﬁeld and ﬂuorescence) with Olympus DP71 and
software, Leica MZ95 microscope (wholemount or sections, bright
ﬁeld) with Olympus DP72 and software, or Leica M165FC (whole-
mount, brightﬁeld) with DP73 and software. A dish of agarose
was used to obtain consistent orientations of small tissues. Adobe
Photoshop 4 and 6 were used to invert immunoﬂuorescence
images and prepare ﬁgures for publication according to editors'
requirements.
Sample recovery for quantitative RT-PCR
Second heart ﬁeld cells were recovered by FACS from Mef2c-
Creþ , R26RYFP/WT E9 and E10 torsos (fromwhich the heart tube had
been completely removed), cut between ﬁrst and second phar-
yngeal arches distally and immediately anterior to the atrial
position posteriorly. Each torso piece was digested in 1% Collage-
nase I (Worthington) diluted 1:9 with Hanks BSS for 15–20 min at
37 1C, pipetted gently to disperse cells, cell-strained and stored on
ice before sorting using the GFP channel on a Beckman Coulter
MoFlo Astria Cell Sorter. Cells from each sample were collected
directly into 500 μl of RLT (Qiagen) to which 20 μl of 1M DTT was
added, transferred to 1.5 ml tubes and stored at 80 1C. RNA was
puriﬁed using RNeasy (Qiagen) and Omniscript (Qiagen) used to
make cDNA. RT-PCR was used to conﬁrm the genotype of each
sample (data not shown).
‘RVþOFT’ tissue was dissected from E9 embryonic hearts
by cutting across the OFT immediately adjacent to the second heart
ﬁeld distally and through the interventricular groove/inner curvature
Fig. 5. Acvr1 is expressed in SHF and endocardium. A–F, E9, E10 from right except F, apical: Strongest expression of Acvr1 in endocardium (arrows) but Bmpr1a similar level
in all cardiac tissues. G, Transgenic bac reporter line construct, nls-lacz-polyA inserted in Acvr1 exon 3. H–O Acvr1 expression in early anterior (I) and later posterior
(M) splanchnic mesoderm (spm, arrows, I,M). Strongest expression in endocardium (e) throughout heart tube from E8.25 (H,J,K,L,N,O). Weaker, intermittant expression in
SHF (J, K, N), myocardium (my) and pharyngeal endoderm (end) by E9 (K). J: section from H, M–O: sections from L. P–S0 0 Acvr1 expression in mid SHF (P, cut above atrium,
viewed from posterior) and distal OFT (rest of heart removed, Q), including morphologically distinct columns of SHF-derived cells (n), some that contribute to aortic (AoT)
and pulmonary trunk (PT) (S–S0 0). Strong expression in endocardium (e); in neural crest cushion cells (C), some epicardial cells (arrowheads R, S0), less expression in
myocardial wall (open arrows). R,transverse, S oblique, sections of distal OFT of WMT βgal-stained E11-11.5. S0 0 is detail from S, S0 from more distal section. C, cushion;
e, endothelium; end, endoderm; my, myocardium; ph, pharynx; spm, splanchnic mesoderm. Scale bar 200 μm, except R0 ,S, 100 μm.
P.S. Thomas et al. / Developmental Biology 390 (2014) 191–207 197
proximally. Each sample was immediately placed in a separate
labeled 1.5 ml tube, excess DPBS removed, and 100 μl RLT buffer
(Qiagen) added. Samples were stored at 80 1C until RNA isolation.
RNA was isolated using RNeasy micro kit (Qiagen) following
Fig. 6. Effect of Bmpr1a-cKO on gene expression in OFT/RV and on OFT/RV development. A, qRT-PCR on E9 RVþOFT: Bmpr1a-cKO RVOFT tissues (pink bars) showed
similar differences in selected gene expression to those of Acvr1-cKO (red bars) relative to controls (blue). However, Tbx1was more highly expressed in Bmpr1a-cKOmutants.
Tdgf1 and Tbx2 in Bmpr1a-cKOs differed very little from controls. npr0.05 Bmpr1a control vs cKO. B–G, E9, E10 hearts, B–E from right, F–G 4-chamber. At E9, RV (arrow) in
two representative Bmpr1a-cKO hearts (B) appeared narrower vs OFT than those of controls (C)(RVþOFT of these samples used for qRT-PCR). At E10, RV appeared wider in
control (D,F) than mutant (E,G) though OFT of similar width (blue lines in D,E; RV and OFT colored yellow in F,G). H–K0 , Progressive loss of BMP Type I receptor alleles
increased abnormality in size and shape of RV, and OFT at E11. Functional (blue) alleles remaining followingMef2c[AHF]-Cre recombination indicated in grid by title: top row,
Acvr1; lower row Bmpr1a;W, wild type; F, ﬂoxed. Arrow (H0–K0) marks position of anterior face of posterior RV which appeared progressively narrower, and ﬂattened apically
(arrowheads, J,K). One Bmpr1a allele appeared more effective at maintaining RV than one Acvr1 allele. OFT also became shorter (J0 ,K0) and narrower (K). Straight RV outlet
route visible (pink arrowheads) in control (H) but twisting in mutant (I). H, K 4 chamber view, RVþOFT colored pink; H0–K0 view from right, RVþOFT outlined. dOFT, distal
OFT. Scale bar 200 μm.
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manufacturer's instructions. All 12 μl of RNA solution was immedi-
ately used to make 20 μl cDNA using Omniscript (Qiagen) and
random primers (Life Technology), and stored at 20 1C. To increase
the number of different gene expressions that could be assessed on
the Acvr1,Mef2c-Cre samples, pre-ampliﬁcation was performed using
the TaqMan Pre Amp master mix (Applied Biosystems) according to
manufacturer's instructions: sense and antisense primers used in the
Roche Universal system (see below) for qRT-PCR were diluted to the
correct concentration and used in place of TaqMan assay reagents.
Ten cycles of pre-ampliﬁcation were performed on 1 μl of cDNA per
20 μl reaction, and the resulting solutions diluted 1:5 with TE, and
stored at 20 1C. Assays on cDNA and pre-ampliﬁed DNA were used
to conﬁrm that relative quantiﬁcation was unaltered following pre-
ampliﬁcation (data not shown).
Real time quantitative PCR
Most experiments were carried out using Universal Probe Library-
based assays (Roche Applied Science) with gene-speciﬁc primer
sequences generated by the manufacturer's online algorithm and
TaqMan Universal PCR master mix (Applied Biosystems) (see
Supplemental Table 3 for sequences). Some used Taqman Assay
reagents (see Supplemental Table 3). 30 μl assays were quantiﬁed
using Applied Biosystems ABI7300 PCR and ViiA7 detection systems
and software. All Ct values were checked by eye. Actb levels were used
to normalize other expression levels. cDNA was diluted to avoid Cts
lower than 18. At least three separate control (Cre negative or
conditional heterozygote) and three separate mutant samples were
assessed for each genotype/condition, where possible from the same
litter, or at least stage-matched.
miRNA assays
Individual E9 RVþOFT pieces were dissected manually as
described above and stored in QIAzol lysis reagent (Qiagen) at
80 1C until RNA isolation using miRNeasy mini kit (Qiagen).
Individual E9 second heart ﬁeld-enriched torso pieces without
heart were dissected manually and stored at 80 1C until RNA
isolation using miRNA puriﬁcation kit from Norgen Biotek. After
quantiﬁcation, samples were shipped overnight on dry ice to LC
Sciences (Houston Texas) who assayed the samples miR-17 and
miR-20a (using Taqman miRNA assays Ids 2308, 0580) and control
RNAs snoRNA202 and noRNA234 (assay Ids 1232, 1234). Three
stage-matched pairs of controls and mutants were used for each
genotype assayed; each of these assayed in triplicate for each
assay, along with a no template control.
Statistical analyses
For histological and expression (qRT-PCR) analyses three or more
samples were analyzed unless otherwise stated. Averages, standard
error and probability (Student's t-test, 1-tailed) were calculated.
Probability (P) equal or less than 0.05 was marked as signiﬁcant.
Results
Acvr1 in the AHF is required for OFT septation and RV development
To address the role of the BMP type I receptor AcvRI in the SHF,
Acvr1 was deleted using Mef2c[AHF]-Creþ driver mice (Verzi et al.,
2005). The resulting Acvr1F/F/Mef2c[AHF]-Creþ embryos (Acvr1-
cKO) lacked most of the functional Acvr1 in the Mef2c[AHF]-Cre
recombination domain (Online Fig. 1).
Defects in post-septation stage Acvr1 mutants
Acvr1-cKO embryos consistently had morphological defects in
ventricular and OFT septation (Fig. 1A–Fb). Membranous ventri-
cular septal defects (VSD; Fig. 1Fa, Fb) were accompanied by OFT,
valve and aortico-pulmonary (AP) trunk septation defects that
formed a spectrum in severity, from the mildest, DORV (double
outlet right ventricle, Fig. 1Da, Ea, Fa) to CAT (common arterial
trunk, from which pulmonary arteries arose directly posteriorly).
In some examples of CAT, septation of the arterial valves had not
occurred, but two trunks of similar size (Online Fig. 2), or one
rudimentary (Fig. 1Eb, Online Fig. 2Lb), were present distally.
Despite these malformations, six (or more) OFT valve cushions/
leaﬂets could often be identiﬁed in partially or distally unseptated
CAT, and coronary ostia were grossly normal (Online Fig. 2).
Defects in arterial tree downstream, and atrial/AV septation
upstream were sometimes found but were not further examined
in this study.
Defects in pre-septation stage Acvr1 mutants
Acvr1-cKO hearts could usually be distinguished morphologi-
cally from controls between E9 and E11 especially by a smaller RV
apex (Fig. 1G–N): The inner curvature could also appear narrower
(Online Fig. 3A, B). A reduction in Bmp signaling could be detected
in recombined Acvr1-cKO heart cells at E9 (Fig. 1I,J) and the
myocardium of these phenotypically abnormal structures was all
recombined by Mef2c[AHF]-Cre (Fig. 1L,O). Unrecombined regions
in control and Acvr1-cKO hearts appeared morphologically indis-
tinguishable (Fig. 1 and data not shown).
It has been suggested that the appropriate degree of OFT
‘rotation’ is required to position aortic and pulmonary trunks with
respect to the ventricular outlets and ventricular septum appro-
priately (Bajolle et al., 2006), which can be defective when BMP
signaling is compromised (Beppu et al., 2009). At E12, mutant OFTs
were found to be (variably) less ‘rotated’ as judged by the angle of
the opposing faces of the parietal and septal cushions to
the embryonic anterior–posterior (A–P) axis (Fig. 1Q–Tb). Sema3c
expression, strongest in sub-pulmonary myocardium which
should be anterior by E12 (Theveniau-Ruissy et al., 2008), was
also abnormal at E11 and 12 in mutants (Fig. 1U–Z).
Other regional differences in wall morphology were also pre-
sent in mutants. By E10, mutant OFT wall was more varied in
thickness (Online Fig. 3C–H): the anterior face of the mid-proximal
OFT wall appeared thicker, and an area of much thinner wall on
the posterior/left side of mutant OFTs surrounded part of the
septal cushion (Online Fig. 3I–W). The wall cells in the thin region
appeared to contain much less cytoplasm and less, poorly orga-
nized, striated muscle myosin than those in other parts of the
wall, or control cells, (Online Fig. 3O,P). Despite this, the cells were
typical of wall, not mesenchymal cell phenotype, as they were
Isl1- and SMαA-positive, and Sox9-negative (Online Fig. 3I–L).
Some apoptosis was present nearby but not localized within the
thin wall itself (Online Fig. 3R–S). This area was barely overlain by
epicardium by E12 (Fig. 3T,U). The right ventricular wall did not
appear to differ in thickness between mutants and controls, and its
trabeculation was not grossly abnormal (data not shown).
Mesenchymal cells are added to the initially cell-free ECM
cushions along the length of the OFT both distally (by migration of
CNCC via the pharyngeal region) and locally, especially proximally,
through EMT from overlying endocardium. At E11, instead of
the usual 2(þ2) cushion arrangement, Acvr1-cKOmutants had highly
populated cushions of differing sizes mid-OFT, and a single mesench-
ymal cushion usually packed to one side distally (Fig. 2A–C,F–H) in
which mesenchyme underwent more cell death at E12 (Online
Fig. 4Q–T). The lumen(s) formed by these cushions were tortuous,
and the endocardium itself was irregular in contour (Fig. 2F–I).
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Proximally, mutant cushions were abnormally shaped, and cushion
continuity to AV cushion absent (Fig. 2D,E,I,J). Cushion mesenchyme
organization was abnormal and Plexina2 expression (expressed by
CNCC) reduced in mutants (Fig. 2K–S). Recombined endocardium
appeared to make little contribution to cushion mesenchyme
(Fig. 2N,T), so CNCC likely contributed most of the mesenchyme as
endocardium appeared increasingly recombined during this period.
Consistent with this, Smad1/5/8 phosphorylation was clearly detect-
able in both control and mutant OFT mesenchyme at E11 (Fig. 2O,U).
OFT cushion morphology was frequently so abnormal in Acvr1-cKO
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that two separate lumens were not maintained through them to the
aortic sac (Fig. 2G, Online Fig. 4F), so they would not have aligned
with the nascent aortic and pulmonary trunk ﬂow routes distally if
formed. Distal SHF-derived OFT and aortic sac wall morphology was
abnormal. A recognizable column of Isl1-positive, MF20-negative SHF
cells on the posterior/left of the distal OFT showed variably reduced
phospho-Smad1/5/8 immuno staining (Fig. 2O,U) and abnormal
morphology in mutants, and lay adjacent to the area of thin
myocardium (Online Fig. 4A–L).
These results show that AcvR1 in SHF-derived cells made an
essential contribution to the development of structures important
for ventricular, OFT and AP septation, and that its removal affected
the behavior of both SHF-derived cells themselves (myocardium
and endocardium) and those genetically normal with which they
interact (CNCC).
Loss of Acvr1 in the SHF results in altered gene expression, increased
cell proliferation and altered regional identity in OFT myocardium
To investigate molecular pathways underlying the effects of
removing AcvR1 function, we chose to study E9, as later events may
be secondary to earlier regulatory defects, and the more complex
anatomy make it harder to discriminate different processes.
Chick anterior SHF explant studies suggest that FGFs and BMPs co-
ordinate the balance between proliferation and differentiation of
anterior SHF progenitors, in part by inhibiting one another via
distinctive groups of ‘synexpressed’ genes (Hutson et al., 2010;
Tirosh-Finkel et al., 2010). Cardiomyocyte and smooth muscle pre-
cursors continue to be added to the mouse heart tube from the
anterior SHF between days 9 and 12 (reviewed by Vincent and
Buckingham (2010)) so to determine if AcvRI-mediated BMP signaling
mediates FGF repression in anterior SHF progenitor cells themselves,
we assessed their gene expression by qRT-PCR at E9 and E10 in FACS-
sorted populations puriﬁed from individual Mef2c[AHF]-Cre-positive
Acvr1F/WT (control) and Acvr1F/F (cKO, mutant) embryos heterozygous
for R26R-YFP. The results (Fig. 3A) were consistent with BMP signaling
being reduced in mutants but FGF synexpression only slightly affected.
We also assessed other genes implicated in SHF-derived heart tube
development, Isl1, Tbx1, and Fgf10 (Cai et al., 2003; Watanabe et al.,
2012; Xu et al., 2004) (Fig. 3A). Average Tbx1 expression was higher at
E9 and Isl1 expression less by E10, in mutants.
AcvR1 might still have mediated Fgf repression in anterior
SHF-derived cells that have joined the heart tube itself, so we
compared the expression of these and other genes implicated in
regulating proliferation and differentiation in the RV/OFT segment
of individual control and mutant heart tubes at E9 (Figs. 3B–G and
4A–G). BMP signaling was reduced in recombined mutant RV/OFT
relative to controls (Fig. 1I,J). Only Fgf8 expression was much
higher in mutants, (not Fgf10, or other synexpression genes,
Fig. 3B, E–F), but the abnormal expression of a number of other
markers in mutants was consistent with a continued proliferative/
less-differentiated phenotype: Isl1, Tdgf1, Tbx1, Wnt2 (Figs. 3B,G;
4A–D). A delay in differentiation did not extend to average
sarcomeric muscle gene expression which was little altered
for those encoding functionally important quantities (Fig. 4A).
Although Nppa levels were on average lower in mutants (data not
shown), WMT ISH showed not only that Nppa expression was still
present in RV trabeculations, but ectopic patches were present
distally beyond the RV chamber and more widely around the
circumference of the OFT at E9, 10 and 11 (Fig. 4F, Online Fig. 4A–C,
data not shown). Nppa expression is normally restricted to the
‘chamber’ myocardium of the ventricles and atrial appendages and
does not occur in AV junction or OFT myocardium. The boundary
between phenotypic chamber and non-chamber in AV region
heart myocardium is tightly regulated by Tbx2, Tbx3, and Tbx20
(Cai et al., 2005). These may play a similar role in OFT (Mesbah et
al., 2012; Ribeiro et al., 2007; Sakabe et al., 2012). Expression of
these (BMP-target) genes was reduced in mutants, as was another
regional marker, Tgfb2 (Fig. 4E,G). Proliferation is normally low in
non-chamber AV region myocardium, but was higher on average
in mutant vs control OFT (Fig. 4H). Note that average expression of
Bmp4 and Bmp2 at E9 was not reduced (Fig. 4E), so their signaling
through other receptors, and in non-recombined cells (such as
neural crest cells) would not be expected to be reduced.
Stabilization of β-catenin did not substantially rescue
Acvr1-cKO phenotype
Embryos lacking Ctnnb1 in SHF have very small RV, CAT and
dysmorphic OFT cushions (Ai et al., 2007). We therefore wondered
whether any relevant Wnt/Ctnnb1 signaling lay downstream of Bmp
signaling and tested this by stabilizing canonical Wnt signaling by
maternal LiCl injection (Tian et al., 2010). A number of genes showed
some normalization in average levels in treated embryos, suggesting
β-catenin signaling might normally act downstream of AcvR1-
mediated BMP signaling to regulate Fgf8, Tgfb2, and Ccnd2 expression.
Tbx3, Tbx20, Isl1, and Wnt2 expression remained abnormal, and LiCl-
treated Acvr1-cKO hearts also remained macroscopically morphologi-
cally abnormal at post-septation stages (Online Fig. 5).
Fig. 7. Generation and analysis of mice carrying the Acvr1ACVR1- and AcvrBmpr1a- knock-in alleles. Note that, for ease of reading, these knock-in alleles are sometimes referred to as
ACVR1-KI (rather than Acvr1ACVR1-KI) and Bmpr1a-KI (rather than Acvr1Bmpr1a-KI) in Figs 7 and 8. A–B, Construction of Acvr1ACVR1- and Acvr1Bmpr1a- knock-in alleles. A: A segment of the
ﬁrst coding exon (3) and next donor splice site of Acvr1was replaced byMyc-tagged ACVR1 cDNA (left panel) or Flag-tagged Bmpr1a cDNA (right panel). B: Targeted ES-cell clones were
ﬁrst identiﬁed by PCR (data not shown) and the correct targeting was conﬁrmed by Southern blotting. DNAs isolated from control (WT) ES cells and putative correctly targeted ES cell
clones (#138 and #149 for Acvr1ACVR1-KI, left panel; #110 and #126 for Acvr1Bmpr1a-KI, right panel) were digested with SacI and detected with an external probe (green bar in A). The
wild-type and targeted alleles show 10.3-kb and 8.3-kb SacI fragments, respectively. C–D, E9 hearts from right: Comparison of RV, OFT morphology of three representative control (C:
no Cre) and Acvr1-cKO with ACVR1-KI mutant (D: Acvr1F/ACVR1-KI,Mef2c[AHF]-Creþ) embryos, showing similar range in size of right ventricle in mutants as controls (arrows). RVþOFTof
these samples used for qRT-PCR shown in E. E, qRT-PCR on E9 RVþOFT Cre0, Acvr1ACVR1-KI-negative controls (blue), Acvr1 F/ACVR1-KI-cKO mutants (red columns). In contrast to Acvr1F/F-
cKO (Fig. 3) and Acvr1F/Bmpr1-KI-cKO (Fig. 8A), average gene expression in mutants is the same or very similar to that in controls. Each bar average of 3 separate samples, 7SEM. F, E15
4-chamber view of heart in Acvr1ACVR1-KI/ACVR1-KI embryo showing normal gross morphology, including complete AP septation. G–H, E9 hearts from right: Comparison of RV, OFT
morphology of three representative control (G: no Cre) and Acvr1-cKOwith Bmpr1a-KI mutant (H: Acvr1F/Bmpr1-KI Mef2c[AHF]-Creþ) embryos, showing variable reduction in size of right
ventricle in mutants (arrows). RVþOFT of these samples used for qRT-PCR, Fig. 6 A,B. I, qRT-PCR on E9 RVþOFTof various controls and mutant genotype samples. We assessed relative
levels of Acvr1Bmpr1a-KI expression in three ways. Transcripts from Acvr1Bmpr1a-KI were speciﬁcally detectable (using ‘KI-Flag’ primers) in Acvr1Bmpr1a-KI control and mutant samples
(purple arrows). The presence of one Acvr1Bmpr1a-KI allele in mutants increased the average level of Bmpr1a by only 14% (compare the results (pink arrows) of ‘Bmpr1a-cds’, which
detects both Bmpr1a and Acvr1Bmpr1a-KI, and ‘50-Bmpr1a’, which only detects Bmpr1a). This suggests that only a subset of cells would have experienced supra-normal levels of Bmpr1a.
Loss of signaling via Acvr1 did not alter the average amount of either Acvr1 or Bmpr1a RNA (orange arrows). Acvr1Bmpr1a-KI >allele was expressed at about the same level as Acvr1WT or
Acvr1Fl: It includes 50UTR exons from Acvr1 but not the Acvr1 cds. The relative level of Acvr1 50UTR remained the same in samples with or without an Acvr1Bmpr1a-KI allele, whereas the
level of ‘Acvr1 cds’ detected was halved when one of the Acvr1 alleles was Acvr1Bmpr1a-KI (brown arrows). These results also suggest that the levels of expression driven by the Bmpr1a
locus and Acvr1 locus may differ (and vary with cell type: see Fig. 5). Genomic DNA contamination (assessed using ‘KI-gen’ primers) did not contribute (data not shown). J–K P0
4-chamber, and oblique right view below: Gross morphology and trunk (AoT, PT) septation in Bmpr1a-cKO also carrying one Acvr1Bmpr1a-KI allele (K) very similar to Cre0 control (J). AoT,
aortic trunk; cds, coding sequence; OFT, outﬂow tract; PV, pulmonary valve; RV, right ventricle. Scale bar 200 μm (C,D,G,H) or 500 μm (F,J,K).
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Do AcvR1 and BmpR1a regulate the same pathways and processes in
anterior SHF-derived cells?
Both AcvR1 and BmpR1 are BMP Type I receptors, yet abnormal
development occurs if the expression of one of these genes is deleted
from the anterior SHF. This may be because they are expressed in
different physical or chronological domains, and/or that each controls
distinctive regulatory events. Using RNA WMT ISH and a novel lacZ-
bac line to report Acvr1 expression, we found expression in SHF and
heart tube cells, as reported for Bmpr1a (Klaus et al., 2007; Song et al.,
2007) but whilst Bmpr1a was broadly expressed at similar levels
(Fig. 5E,F), Acvr1 was most strongly expressed in endocardium, and
cushion mesenchyme (Fig. 5A–D, H, K–O, R). Weaker expression was
also found in splanchnic lateral plate mesenchyme, variably in SHF
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cells and gradually increasing in myocardial cells after tube formation.
It was detectable in SHF cells at E10 and in non-myocardial OFT cells at
E11 (Fig. 5H–S0 0).
We also found that most of the genes showing altered expression in
Acvr1-cKO RVþOFT at E9 were similarly altered in Bmpr1-cKO (Fig. 6A).
The morphological phenotype of Bmpr1-cKOwas also similar, but more
extreme (compare Fig. 1H vs 6C, and Online Figs. 3 and 4 vs 6)
including small RV (E9-10), abnormal OFT cushion development,
abnormal OFT wall and CAT-consistent morphology at E12. All were
dead by E13. Hearts containing only one or no Acvr1/Bmpr1a alleles
also showed progressively more abnormal RV and OFT phenotypes
(Fig. 6H–K0), so mal-development might be the result of a lack of
sufﬁcient BMP Type I receptor capacity remaining for normal devel-
opment if only either Acvr1 or Bmpr1a were absent. To test this, we
added Bmpr1a and ACVR1 back in place of Acvr1 genetically in Acvr1-
cKOmice by making two novel knock-in mouse lines carrying an Acvr1
allele in which either Bmpr1a cDNA (to make Acvr1Bmpr1a-KI) or ACVR1
cDNA (to make Acvr1ACVR1-KI) coding sequence under Acvr1 locus
control replaced the endogenous Acvr1 sequence (Figs. 7 and 8).
Acvr1ACVR1-KI allele (‘ACVR1A-KI’) functioned similarly to Acvr1WT, and
the presence of Acvr1Bmpr1a-KI (‘Bmpr1a-KI’) was not lethal, as
Acvr1ACVR1-KI/ACVR1-KI homozygote knock-in, Acvr1Bmpr1a-KI/ACVR1-KI,
Acvr1WT/Bmpr1a-KI and Cre-negative Acvr1F/Bmpr1a-KI animals were viable,
fertile and grossly normal (data not shown), and Acvr1ACVR1-KI/F-cKO
resembled Cre-negative controls in morphology and E9 RVþOFT
gene expression (Fig. 7C–F). However, only limited normalization of
average gene expressionwas found in E9 RVþOFT from Acvr1Bmpr1a-KI/F-
cKO at E9: Tbx1 and Wnt2 to control levels, Smad6 partially restored,
and Tgfb2 from under-expression to over-expression (Fig. 8A,B). From
E12, these embryos still displayed a spectrum of septation defect
phenotypes ranging from CAT to successful AP septation (Fig. 8,
Table 1), but with variable normalization of mid-OFT cushion orienta-
tion, organization and number, and restoration of OFT wall thickness
(Fig. 8La–Pb). This was despite the fact that expression of Acvr1Bmpr1a-KI
RNA could be detected at E9 (Fig. 7I), and produced functional protein
as there was some improvement in average Smad6 expression at
E9, and Bmpr1a-cKO, Acvr1WT/Bmpr1a-KI mice survived beyond E13
and showed a substantial improvement in morphology (Fig. 7J,K,
Fig. 8Q–W, Table 1).
We therefore conclude that AcvR1 and BmpR1 each mediate
signaling required for normal development in the anterior SHF-
derived tissues, and propose that the abnormalities that arise from
the deletion of either gene may result in part from a Tbx2/3/20-
mediated mis-regulation of the regional identity of the OFT myocar-
dium. Despite the similarities in their location and in the effects of
their absence, AcvR1 and BmpR1a play some non-redundant roles in
the development of anterior SHF-derived cardiovascular tissues.
Discussion
Implications for BMP-dependent arterial pole cardiovascular
morphogenesis
In this, the ﬁrst report of the Acvr1 arterial pole cKO phenotype,
we have shown that a spectrum of SHF-related cardiovascular
septation defects occurred but survival was possible to birth.
Analysis of morphology at different times and positions along
the OFT suggests a model in which the degree of distal (aortico-
pulmonary trunk) septation is in part dependent on the correct
positioning of two nascent OFT lumens in relation to those formed
by the most distal component of the septation complex, a neural
crest-dependent protrusion in the dorsal wall of the aortic sac,
which lies between the routes to pharyngeal arch III,IV vessels and
arch VI vessels. Loss or mis-positioning of one lumen means that a
permanently unseptated truncal region, even if more distal septa-
tion still occurs. The mechanism underlying the variability is still
unclear but key morphological features of normal and abnormal
development of this region, and similarity to human congenital
malformations of the variety of abnormal phenotypes we saw in
Acvr1-cKO are examined in detail in Anderson et al. (2012).
We detected reduced Bmp signaling via Smad1/5/8 phosphor-
ylation in recombined OFT wall cells at both E9 and E11, but it is
not possible solely from this approach to determine which events
are key to normal morphogenesis without considering morpholo-
gical evidence. Pre-septation, we found that OFT ‘rotation’ was
less than normal, and that OFT wall morphology was regionally
abnormal. This could be because speciﬁc SHF populations failed to
make their normal contribution to the OFT. RV/OFT walls are
formed from cells originating in different areas of SHF (Bertrand et
al., 2011; Dominguez et al., 2012; Takahashi et al., 2012) and their
regional contribution to the tube may act to displace others in
relation to the axes of the rest of the heart, i.e., relative ‘rotation’
(Bajolle et al., 2006; Scherptong et al., 2012), including forming the
distinctive subpulmonary myocardial population essential for
normal truncal origin position and proximal trunk wall cells.
We observed consistent regions of abnormally thin and thick
OFT walls, areas of thickened trunk wall, and an insufﬁciency of
sub-pulmonary myocardium suggesting AcvR1 and BmpR1a-
mediated BMP signaling is required for normal formation, location
and differentiation of speciﬁc SHF cell populations. Both OFT wall
thickness and ‘rotation’ were improved by adding Bmpr1a-KI
expression to Acvr1-cKOs consistent with the rescue of a related
‘thin wall’ model (Wang et al., 2010).
OFT cushion morphology is important for OFT septation but
also affected lumen position and number in both Acvr1- and
Fig. 8. Effect of Bmpr1a knock-in into Acvr1 locus (Bmpr1a-KI) on gene expression and OFT morphology. A, qRT-PCR on E9 RVþOFT: controls (no Cre, no Bmpr1a-KI),
blue columns; Acvr1-cKO with Bmpr1a-KI mutants (i.e. Acvr1F, Bmpr1a-KI, Mef2c[AHF]-Creþ), purple columns; and B, Acvr1-cKO (red columns) vs Acvr1-cKO with Bmpr1a-KI
(purple columns) showing that when Acvr1 was replaced by expression from one allele of Bmpr1a cDNA in the Acvr1 locus average Tbx1 and Wnt2 expression became
normal, and Tgfb2 expression was over rather than under expressed (arrows) but expression of other genes shown remained only partially normalized (Smad6) or abnormal
in a similar way to Acvr1 cKO. Each bar average of 3, 7SEM, npr0.05. E12 4-chamber views: Gross morphology of control, mild and severe Acvr1-cKO and Bmpr1a-cKO
without (C, Ja, Jb, Q) and with Bmpr1a-KI (D, Ka, Kb, R) dissected to reveal trunks where possible. Presence of Bmpr1a-KI in Acvr1-cKO improved morphology of RV, OFT in
some (Ka vs Ja) but not all (Kb vs Jb) embryos, enlarging RV size and improving OFT orientation (R vs Q, green area) in Bmpr1a-cKO. Blood in arterial trunks shows septation in
controls and mild Acvr1-cKO (Ka). E12 sections, transverse to OFT, H&E: Control (E-I), Acvr1-cKOmild (Ka–Pa) and severe (Kb–Pb) phenotype and Bmpr1a-cKO (R–W), all with
Bmpr1a-KI. OFT, from arterial trunk level (top row, sections) to proximal OFT (bottom row). In presence of Bmpr1a-KI, all cKO showed some improved wall thickness and
cushion organization; but uneven wall thickness and distal epicardium (ep) was still seen where distal septation failed. In mild Acvr1-cKO with Bmpr1a-KI, trunk septation
and mid-OFT cushion formation including condensed areas (bluen, arrows), myocardial growth into cushion (red arrowhead) more similar to control, but proximal cushion
morphology (blackn) and continuity with AV cushion (open arrow, Pa) absent. In the severe mutant with Bmpr1-KI, trunk septation failed (Lb), uneven trunk wall (Lb, short
arrow), RVO lumen displaced (open arrowhead), distal (Mb) and proximal cushions abnormal (Pb), mid- to proximal OFT anterior wall too thick (red lines), some wall very
thin (arrowheads Mb, Nb) but mid-OFT orientation relatively normal. In Bmpr1-cko with Bmpr1a-KI, trunk septation only partial, uneven trunk wall (K, short arrows),
separate RVO lumen lost (open arrow) but mid- and proximal orientation, condensation (blue arrows), intercalated leaﬂet (green*) and proximal cushion continuity with AV
cushion (W, black arrow), wall thickness except proximally (red lines) similar to control. Compare with Acvr1- and Bmpr1a-cKO E12 morphology in Figs. 1 and 2 and Online
Figs. 2–4. Spaces between cushions and walls are artifacts. Ao, ‘aortic’ lumen; AV, atrioventricular cushion; ep, epicardium; my, myocardium; P, ‘pulmonary’ lumen. Scale bar,
200 μm.
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Bmpr1a-cKOs particularly distally. The regulation of OFT cushion
morphogenesis, size and location remains poorly understood at
the molecular level. Certain SHF populations, including those
identiﬁed by Sizarov et al. (Sizarov et al., 2012) and abnormal in
morphology and Smad1/5/8 phosphorylation in our models, might
play a role in the maintenance of separate nascent truncal lumens
close to the OFT wall, perhaps via effects on OFT cushion morpho-
genesis. As many endocardial/endothelial cells are also recom-
bined by Mef2c[AHF]-Cre, their behavior and signaling may also
contribute, especially as cushion shape regulation is sensitive to
ﬂow (Colvee and Hurle, 1983; Manner et al., 1993) which might be
expected to be abnormal from at least E9 as the right ventricle is
abnormally small. However, as AP and valve septation were
normal in endothelium-speciﬁc Acvr1-cKOs (Wang et al., 2005)
an isolated role in septation failure is unlikely. Abnormalities in
OFT mesenchymal behavior including abnormal (circumferential)
alignment, and elevated cell death distally, were found in Acvr1-
cKOs from E11, but also some degree of normal organization and
gene expression (Plxna2, Sox9). Although Bmp4 expression has
been shown to be important in normal OFT cushion development
(Jia et al., 2007), other factors may be abnormal in our model, as
average expression of Bmp4 was normal in mutant tissues at E9,
and mesenchyme (mostly genotypically normal CNCC) stained
strongly for phospho-Smad1/5/8 at E11, and expressed BMP-
sensitive Sox9 in both control and mutants. However, we did see
abnormalities in regional expression of Sema3C (Bajolle et al.,
2008) and elevated levels of OFT Fgf8 expression may have
affected cushion shape and cell number proximally (Sugi et al.,
2003). Contribution to OFT cushion mesenchymal cells by EMT
from recombined cells in Acvr1-cKO appeared reduced at E10,
consistent with previous results (Wang et al., 2005). Neural crest
cells probably made a greater contribution to cushions including
valve leaﬂets where non-CNCC normally contribute, including to
OFT valve leaﬂets, but proximally, continuity between OFT and AV
cushions still formed poorly, contributing to the VSD phenotype in
Acvr1 mutants. The walls over which these usually form are totally
recombined by Mef2c[AHF]-Cre, and were not well rescued by the
addition of Bmpr1a-KI expression to Acvr1 mutants, unlike
Bmpr1a-cKO, consistent with AcvR1 playing a speciﬁc role in their
formation.
Role of AcvR1-mediated signaling in regulating gene expression in
SHF-derived cells
We did not ﬁnd strong evidence that an autocrine element
of the ‘BMP/FGF balance’ model (Tirosh-Finkel et al., 2010) in
recombined cells contributed to the Acvr1-cKO phenotype. How-
ever, altered expression levels of other genes implicated in pre-
cursor/proliferation (elevated) and differentiation (reduced) were
found in E9 RVþOFT Acvr1 mutants: Fgf8 (promotes SHF prolif-
eration (Ilagan et al., 2006; Park et al., 2006)), Isl1 (needed for SHF
progenitors (Cai et al., 2003)), and Tdgf1 (Cripto, associated with
muscle precursor development/proliferation (Guardiola et al.,
2012)) elevated; andWnt2 (required for myocardial differentiation
(Onizuka et al., 2012; Tian et al., 2010)) reduced. Fgf8, Isl1 and
Wnt2 are all Tbx1 targets (Liao et al., 2008); average expression of
Tbx1 itself was mildly elevated in E9 SHF, (where it maintains
proliferation (Zhang et al., 2006)) so may contribute to their
altered expression as they enter the heart tube. Elevated expres-
sion of Tbx1 detected in E9 RVþOFT in Acvr1- and Bmpr1a-cKO
mutants is hard to detect in OFT wall by WMT ISH, but cells
present distally by the aortic sac at E9 (Chen et al., 2009) would be
included in RVþOFT by dissection. Not only was average Fgf8, Isl1,
and Tdgf1 expression elevated at E9, but their expression also
extended along the OFT more proximally and for longer in time in
Acvr1-cKO, also ‘less differentiated’ phenotypes. FGF signaling has
also been implicated in the differentiation of distal SHF into
arterial smooth muscle of the trunk walls (Hutson et al., 2010).
Some ‘smooth muscle’ genes are normally expressed in early
embryonic myocardium (such as Acta2 (Franco et al., 1999)) so
were not assayed, but the higher expression of Myh11 (even
though at a very low level), not normally expressed until E14,
may reﬂect a subtle shift in transcriptional milieu to favor smooth
muscle-related fate.
T-box transcription factors, Tbx2, 3 and 20 are good candidates
to be key downstream targets for AcvR1-dependent BMP signaling
and the lack of expression of which could be responsible for the
phenotypes we report here in Acvr1-cKO. That levels of all three
are reduced in our mutants could result in a phenotype where
partial loss of any one alone would not. They can be directly up-
regulated by BMP R-Smad1/5/8 signaling (Singh et al., 2009; Yang
et al., 2006). Tbx2 and 3 have previously been identiﬁed as targets
in OFT development in Bmpr1a/Isl1-Cre-cKO model (Yang et al.,
2006) and Tbx20 as required for suppression of expression of Isl1
(Cai et al., 2005) and expression of Tbx3 in the AV (Cai et al., 2011).
Their individual and double KOs have smaller RV and abnormal
OFT (Mesbah et al., 2012). Study of their roles in AV morphological
development have shown that they repress the expression of
‘chamber’ (i.e., ventricular apex and atrial appendage) region
genes, including Nppa, morphology (trabeculation) and higher
proliferation (Ribeiro et al., 2007); and thereby maintain the
presence of cushions and formation of cushion mesenchyme,
Table 1
Incidence of different arterial trunk/OFT phenotypes.
Acvr1-cKO Acvr1-cKO,Bmpr1a-KI Bmpr1a-cKO Bmpr1a-cKO, Bmpr1a-KI
2 Trunksa E12-E15: 8 (53%) E12-E15: 5 (63%) E12-E14: 0 (0%) E12-P0: 4 (100%)c
E12-P0: 17 (40%)
1 Trunk E12-E15: 7 (47%) E12-E15: 3 (37%) E12 (live): 6 (100%) E12-P0: 0 (0%)c
E12-P0: 25 (60%) E13-14 (deadb): 15 (100%)
Mutant genotype samples were categorized according to number of arterial trunks. ‘Two trunk’ phenotype includes DORV (where AP and OFT valve septation complete) but
also CAT with AP septation variably distal to the level of the valve leaﬂets (no valve septation). ‘One trunk’ phenotypes showed no AP septation, such that the pulmonary
arteries arose from the back of the common arterial trunk.
Range of stages of embryos include in totals is indicated, with percentage (in brackets) of samples of those stages genotyped as cKO showing that number of trunks. These
data include dead embryos/newborns in which genotype and anatomy could be determined.
a Complete AP and valve septation was present in two Acvr1-cKO embryos, one Acvr1-cKO with Bmpr1a-KI embryo and two Bmpr1a-cKO with Bmpr1a-KI embryos.
b Although variably necrotic, Bmpr1a-cKO mutant anatomy could still be determined at E13-14, and limb and eye morphology resembled that of E12 at the latest. The
cause of death was not obviously of cardiac origin. An extra-cardiac explanation for lethality has been suggested (Briggs et al., 2013).
c The marked improvement in cardiovascular morphology of Bmpr1a-cKO in the presence of Bmpr1a-KI contrasts with the more limited effects of the allele on Acvr1-cKO
anatomy overall. A population of Mef2c[AHF]-Cre-recombined cells which expresses both Acvr1 and Bmpr1a normally but in which BmpR1A performs an essential role for
embryonic survival that AcvRI cannot, is implied by the survival and development well beyond E12 of otherwise Bmpr1a-cKO mice.
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through expression of genes such as Has2 and Tgfb2. Average Tgfb2
expression was also reduced in Acvr1- and Bmpr1a-cKO, and the
Tgfb2-KO phenotype also resembles that of Acvr1-cKO, including a
range of OFT/AP septation defects from DORV to CAT with variable
degree of distal trunk septation and failure of cushion fusion
(Bartram et al., 2001). Mis-expression of Nppa and Tgfb2, and
thicker anterior proximal OFT myocardium in Acvr1-cKO suggest
that at least the boundary between the right ventricle chamber
and non-chamber mid-proximal areas of the OFT wall was less
distinct and OFT non-chamber identity compromised. Higher
expression of muscle genes in part of the OFT myocardium
together with a reduced contribution by the smaller RV might
contribute to the similarity of average muscle gene expression in
Acvr1-cKO and control samples. Like Isl1 expression, Tbx2 and Tbx3
expression only became abnormal in Acvr1-cKO after SHF had
joined the heart tube, suggesting an AcvR1-mediated process
maintained their expression and Tbx20 from this point. Despite
apparently normal levels of Bmp4 and higher than normal Bmp2 at
E9, remaining Type I BMP receptors were insufﬁcient to normalize
levels of these three genes in Acvr1-cKO. There is feedback
regulation between these T-box factors (Cai et al., 2011; Dupays
et al., 2009; Gavrilov et al., 2013), so Acvr1-cKO is an interesting
model where all three were reduced but none was absent. Again,
the failure in Acvr1- and Bmpr1a-cKO to establish correct chamber
and non-chamber-type regions would represent a failure of normal
differentiation.
The effects of elevation of Wnt/beta-catenin signaling (by LiCl
injection) or BMP signaling (using Acvr1 locus-regulated Bmpr1a-
KI or ACVR1-KI) on average gene expression in E9 RVþOFT suggest
a variety of regulatory pathways controlled the expression of
genes altered in Acvr1-cKO (Online Fig. 7). Although Tbx2,3,20
expression was not normalized, the downstream target gene Tgfb2
became over-expressed by Bmpr1a-KI in Acvr1-cKO. This may have
enabled the degree of context-dependent improvement in mor-
phological development. Comparison of gene expression at E9
with morphological phenotypes suggests additional genes regu-
lated by AcvR1-mediated signaling remain to be identiﬁed, and
that more region-speciﬁc studies are needed to advance under-
standing of this complex environment.
AcvR1 as one component of BMP signaling in SHF development
AcvR1 and BmpR1a are the principal Type I BMP receptors
expressed in the developing RV and OFT wall. Either one alone is
insufﬁcient to maintain normal development in arterial pole SHF-
derived structures, or expression of known BMP-Smad target
genes such as Smad6, Msx2, Id1 and Bambi at E9 even though
Bmpr1a and Acvr1 are expressed at grossly similar times and
places. Nevertheless, they appear to regulate many of the same
processes (gene expression, morphogenesis). The sequential loss
of their functional alleles appeared to create a somewhat gradient-
like of loss of normality of morphology (Fig. 6), and of gene
expression (though sensitivity/mechanism varied from gene to
gene) (Online Fig. 7). Yet even though Acvr1Bmpr1a-KI was expressed
at E9 (Fig. 7I) and substantially rescued Bmpr1a-cKO phenotype
despite its expression being restricted to the Acvr1 expression
domain, Bmpr1a-KI did not restore expression of all assayed genes
to normal levels in Acvr1-cKO RVþOFT at E9. Surprising amongst
these were Smad6, Tbx2, 3 and 20. One interpretation is that AcvR1
and BmpR1a have some non-redundant roles, consistent with their
known difference in ligand preference (Macias-Silva et al., 1998), but
the similarity of gene expression and phenotypes affected suggest
that their signaling also needs to be co-ordinated or combined to be
effective. It may also be restricted to a very speciﬁc region and time.
There is evidence in other models for heteromeric receptor forma-
tion (Little and Mullins, 2009; Shimmi et al., 2005), but other
mechanisms, such as interaction with as yet unidentiﬁed regulatory
factors, may be responsible.
AcvR1 in congenital heart disease
Although AcvR1 itself is best known for its constitutively active
mutant form that results in ﬁbrodysplasia ossiﬁcans progressiva
(Shore et al., 2006), the ACVR1 L343P allele was identiﬁed in a
screen of atrioventricular septal defect patients and shows greatly
reduced signaling capacity and transcriptional activity (Smith
et al., 2009). Abnormalities in a number of genes, the normal
expression of which we found dependent on AcvR1 have already
been identiﬁed as causative of CHD (TBX20 (Kirk et al., 2007) and
TGFB2 (Gao et al., 2012; Lindsay et al., 2012)), or as potential
contributory (TBX2 (Pang et al., 2013),TBX3 (Chen et al., 2013),
BMP4 (Goracy et al., 2012), TDGF1 (Roessler et al., 2008; Wang
et al., 2011) and ISL1 (Stevens et al., 2010)). Even a mildly defective
allele of Acvr1 could inﬂuence the expression of many genes
known to be required for normal heart development and when
in combination with other such alleles of these genes account for
cases of CHD. The results reported here illustrate the importance
of considering the effect of abnormal, though apparently ‘redun-
dant’, gene products in the understanding of human CHD.
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Glossary
AoT: Aortic trunk;
AoV: Aortic valve;
AP: Aortico-pulmonary;
AV: Atrioventricular (region);
BMP: Bone morphogenetic protein;
CAT: Common arterial trunk;
cHet: conditional heterozygote;
cKO: conditional knock out;
CNCC: Cardiac neural crest-derived cells;
CHD: Congenital heart disease;
DORV: Double outlet right ventricle;
E9: Embryonic day 9;
EMT: Epithelial-to-mesenchymal transformation;
FGF: Fibroblast growth factor;
ISH: in situ hybridization;
LA: Left atrium;
LV: Left ventricle;
OFT: Outﬂow tract;
P0: Postnatal, within ﬁrst 24–h;
PT: Pulmonary trunk;
PV: Pulmonary valve;
RA: Right atrium;
RV: Right ventricle;
RVO: Right ventricular outlet;
SHF: Second heart ﬁeld;
SmαA: Smooth muscle alpha actin;
VSD: Ventricular septal defect;
WMT: Whole mount (pieces of tissue, not sections).
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